-
公开(公告)号:US20110288172A1
公开(公告)日:2011-11-24
申请号:US13198928
申请日:2011-08-05
IPC分类号: A61K31/19 , A61P29/00 , A61P23/00 , A61K31/205 , A61P17/00
CPC分类号: A61K31/573 , A61K8/31 , A61K8/345 , A61K8/361 , A61K8/365 , A61K8/368 , A61K8/49 , A61K8/73 , A61K9/0014 , A61K31/19 , A61K31/535 , A61K31/5375 , A61K31/56 , A61K45/06 , A61K47/44 , A61K2800/524 , A61Q19/00 , A61Q19/007 , A61K2300/00
摘要: Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid.
摘要翻译: 皮肤病学组合物(制备和使用方法)包括一种或多种麻醉剂和/或一种或多种抗炎剂和/或铵,钠和钾盐,优选α-羟基酸的组合。
-
公开(公告)号:US5126145A
公开(公告)日:1992-06-30
申请号:US536184
申请日:1990-06-11
IPC分类号: A61K9/22 , A61K9/20 , A61K31/455 , A61K47/38
CPC分类号: A61K31/455 , A61K9/2013 , A61K9/2054 , Y10S514/96 , Y10S514/964
摘要: A sustained or controlled release tablet is disclosed. The tablet comprises a water soluble medicament, a hydroxypropyl methylcellulose having sustaining action, a pharmaceutical binding agent, and a hydrophobic component.
摘要翻译: 公开了持续或控释片剂。 片剂包含水溶性药物,具有维持作用的羟丙基甲基纤维素,药物结合剂和疏水组分。
-
公开(公告)号:US20160000672A1
公开(公告)日:2016-01-07
申请号:US14851203
申请日:2015-09-11
IPC分类号: A61K8/365 , A61K8/36 , A61K8/368 , A61K31/19 , A61K31/5375 , A61K8/31 , A61K8/34 , A61K8/73 , A61Q19/00 , A61K31/573
CPC分类号: A61K31/573 , A61K8/31 , A61K8/345 , A61K8/361 , A61K8/365 , A61K8/368 , A61K8/49 , A61K8/73 , A61K9/0014 , A61K31/19 , A61K31/535 , A61K31/5375 , A61K31/56 , A61K45/06 , A61K47/44 , A61K2800/524 , A61Q19/00 , A61Q19/007 , A61K2300/00
摘要: Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid.
-
公开(公告)号:US08013017B2
公开(公告)日:2011-09-06
申请号:US12479524
申请日:2009-06-05
CPC分类号: A61K31/573 , A61K8/31 , A61K8/345 , A61K8/361 , A61K8/365 , A61K8/368 , A61K8/49 , A61K8/73 , A61K9/0014 , A61K31/19 , A61K31/535 , A61K31/5375 , A61K31/56 , A61K45/06 , A61K47/44 , A61K2800/524 , A61Q19/00 , A61Q19/007 , A61K2300/00
摘要: Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid.
摘要翻译: 皮肤病学组合物(制备和使用方法)包括一种或多种麻醉剂和/或一种或多种抗炎剂和/或铵,钠和钾盐,优选α-羟基酸的组合。
-
公开(公告)号:US20090247632A1
公开(公告)日:2009-10-01
申请号:US12479524
申请日:2009-06-05
CPC分类号: A61K31/573 , A61K8/31 , A61K8/345 , A61K8/361 , A61K8/365 , A61K8/368 , A61K8/49 , A61K8/73 , A61K9/0014 , A61K31/19 , A61K31/535 , A61K31/5375 , A61K31/56 , A61K45/06 , A61K47/44 , A61K2800/524 , A61Q19/00 , A61Q19/007 , A61K2300/00
摘要: Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid.
摘要翻译: 皮肤病学组合物(制备和使用方法)包括一种或多种麻醉剂和/或一种或多种抗炎剂和/或铵,钠和钾盐,优选α-羟基酸的组合。
-
公开(公告)号:US5462740A
公开(公告)日:1995-10-31
申请号:US122685
申请日:1993-09-17
CPC分类号: A61M3/02 , A61K9/0031 , A61M5/24 , A61M2005/311 , A61M5/502 , Y10S424/15 , Y10S514/964
摘要: This invention provides a rectally administered composition for inhibiting epileptic seizure and to its methods of use. The composition contains, in a suitable solvent, an anti-epileptic agent for inhibiting epileptic seizure, a buffer for maintaining pH, and a thickener for imparting a viscosity to the composition effective for rectal administration by injection to a patient in epileptic seizure.
摘要翻译: 本发明提供了用于抑制癫痫发作的直肠给药组合物及其使用方法。 该组合物在合适的溶剂中含有用于抑制癫痫发作的抗癫痫剂,用于维持pH的缓冲液,和增稠剂,用于通过注射给患者癫痫发作给予直肠给药有效的组合物的粘度。
-
公开(公告)号:US5268181A
公开(公告)日:1993-12-07
申请号:US905785
申请日:1992-06-29
IPC分类号: A61K9/22 , A61K9/20 , A61K31/455 , A61K47/38 , A61K9/30
CPC分类号: A61K9/2013 , A61K31/455 , A61K9/2054 , Y10S514/824
摘要: The invention provides a therapeutic method to treat hyperlipidemia by administering to a human patient a single daily dose of a prolonged release dosage form of niacin, so that nocturnal cholesterol synthesis is effectively suppressed.
摘要翻译: 本发明提供了一种治疗高脂血症的治疗方法,其通过向人类患者施用单次日剂量的烟酸延长释放剂型,从而有效抑制夜间胆固醇合成。
-
-
-
-
-
-